EJ Brandreth, MBA

Mr. Brandreth is responsible for all quality and compliance functions across clinical development, manufacturing and other operational areas that support INOVIO’s broad pipeline of DNA medicines. With over 30 years in life sciences including small molecules, devices and a wide variety of pivotal biotechnology products, Mr. Brandreth is a key member of the senior leadership team with a track record of moving pipeline candidates such as Rituxan^®, Zevalin^®, Aldurazyme^® and Naglazyme^® to commercialization.

Prior to joining INOVIO, Mr. Brandreth had a successful career transitioning start-up clinical biotech operations into commercial entities; he contributed to the success of several biopharmaceutical companies through his strong leadership of the quality and compliance areas. He holds an MBA from University of the Pacific and a B.A. in Biology from University of California, San Diego.